蒂奥卡纳通过破坏细胞完整性来发挥抗结核活性
Zhanpeng Chen1, Xiaoming Wang1, He Zhang1
1National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
European journal of pharmacology
|August 30, 2025
概括
蒂奥卡纳对结核病 (TB) 菌株具有强烈的抗菌作用,为其提供了潜在的新疗法. 它破坏了病原体
科学领域:
- 微生物学
- 药物发现
- 传染性疾病
背景情况:
- 耐药结核病和人类免疫缺陷病毒 (HIV) 的同时感染需要新的抗结核药物.
- 传统的结核病治疗是漫长的,有毒的, 对抗性菌株越来越无效.
研究的目的:
- 研究蒂奥卡纳的抗结核活性和抗菌机制.
- 评估蒂奥卡纳作为一种潜在的新型治疗药物对抗Mycobacterium tuberculosis (Mtb).
主要方法:
- 对Mtb H37Ra和H37Rv的最小抑制度 (MIC) 的确定.
- 在使用Mtb H37Ra CYP121条件突变剂和pristimycin的情况下评估了tioconazole的活性.
- 检查与tioconazole治疗的Mtb细胞中的形态变化和细胞内ATP水平.
主要成果:
- 蒂奥卡纳具有显著的抗菌活性,MIC为4μg/ ml (Mtb H37Ra) 和1μg/ ml (Mtb H37Rv).
- 当使用胆固醇或棕酸作为单一碳来源时,MIC对Mtb H37Ra降至2μg/ml.
- 提奥卡纳治疗诱导细胞表面胀/ 凸,并将细胞内ATP水平降低了~50%,表明细胞完整性和脂质代谢受到破坏.
结论:
- 蒂奥卡纳对Mtb具有强大的抗结核活性.
- 药物似乎通过破坏细胞壁和细胞膜完整性来发挥作用,这可能是通过抑制脂质代谢.
- 蒂奥卡纳是开发新抗结核药物的有希望的候选药物.
更多相关视频
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
11.7K
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
3.2K
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
